Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of CXCL8, IL1A, and IL1B as Hub Genes of Therapeutic Resistance in Glioblastoma Multiforme via Bioinformatics Analysis

29 Aug 2025

Abstract excerpt

BACKGROUND/AIM: Glioblastoma multiforme (GBM) is a highly aggressive, treatment-resistant brain tumor with a dismal prognosis, and identifying key molecules involved in its therapeutic resistance is essential to improve patient outcomes. This study was undertaken to identify hub genes associated with the radioresistance and temozolomide (TMZ) resistance of GBM using bioinformatics analysis. MATERIALS AND METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine receptors and signaling
Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40883024
DOI: 10.21873/cgp.20537

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of CXCL8, IL1A, and IL1B as Hub Genes of Therapeutic Resistance in Glioblastoma Multiforme via Bioinformatics AnalysisPMID 40883024Read ↗

Identifying Hub Genes Driving Glioblastoma Multiforme Progression through Transcriptomics: To Discover Potential Diagnostic and Therapeutic TargetsSemantic proximity Read ↗

Deciphering hub genes as potential therapeutic target involved in progression of Glioblastoma multiforme disease: A multi-omics approachSemantic proximity Read ↗

Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technologySemantic proximity Read ↗

Identification of Hub Genes and Key Pathways Associated with Anti-VEGF Resistant Glioblastoma Using Gene Expression Data AnalysisSemantic proximity Read ↗

Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics AnalysisSemantic proximity Read ↗

Identification of an Immune-Related Prognostic Risk Model in GlioblastomaSemantic proximity Read ↗

Identification of Potential Therapeutic Targets and Biomarkers for Glioblastomas Through Integrative Analysis of Gene Expression DataSemantic proximity Read ↗

Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysisSemantic proximity Read ↗

Identification of Key Genes and Signaling Pathways Associated with the Progression of Glioblastoma multiformSemantic proximity Read ↗

Bioinformatic Identification of a Six-Gene Biomarker Signature for Prognostic and Diagnostic Insight in GlioblastomaSemantic proximity Read ↗

Identification and Analysis of Molecular Pathways and Key Candidate Biomarkers in Glioblastoma MultiformeSemantic proximity Read ↗

Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of GlioblastomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.